Outcomes of supercritical carbon dioxide-processed cadaveric fascia lata pubovaginal sling for female stress urinary incontinence: a prospective single-surgeon cohort

Abstract Purpose Supercritical carbon dioxide (SCCO 2 ) processing may preserve the structural properties of cadaveric fascia while avoiding donor-site morbidity associated with autologous fascial harvest. Clinical outcomes of SCCO₂-processed fascia lata have not previously been reported in continence surgery. Our study evaluated efficacy and safety outcomes following SCCO₂-processed cadaveric fascia lata pubovaginal sling (PVS) surgery for female stress urinary incontinence (SUI). Methods This prospective, single-centre, single-surgeon observational cohort included 24 consecutive women undergoing SCCO₂-processed fascia lata PVS surgery. Patient-reported outcomes were assessed using the International Consultation on Incontinence Questionnaire–Urinary Incontinence Short Form (ICIQ-UI SF) and Patient Global Impression of Improvement (PGI-I) at 6 weeks, 6 months and 12 months. Primary outcome was change in ICIQ-UI SF and PGI-I from baseline to 12 months. Perioperative and graft-related complications were recorded prospectively. Results Baseline median ICIQ-UI SF was 15.5 (IQR 14–16). Twelve-month outcome data were available for 18 participants with a median ICIQ-UI SF of 4 (IQR 0–6), and a median within-participant improvement of 11 points (IQR 9–15; p<0.001). Thirteen (72.2%) reported being “very much better” on PGI-I; subjective SUI cure / improvement were reported by 17/18 (94.4%). Graft exposure occurred in 3/24 (12.5%). Conclusion SCCO₂-processed cadaveric fascia lata PVS was associated with substantial improvement in patient-reported continence outcomes at 12 months. These preliminary findings support further prospective evaluation with larger comparative cohorts and longer follow-up.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-17
DOI
https://doi.org/10.21203/rs.3.rs-11621335/v1
Primary Topic
Pelvic floor disorders treatments
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Outcomes of supercritical carbon dioxide-processed cadaveric fascia lata pubovaginal sling for female stress urinary incontinence: a prospective single-surgeon cohort

Judith T. W. Goh, H Kyaw, Hannah G. Krause, Yu Hwee Tan et al.
Research Square
Pelvic floor disorders treatments
preprint

Outcomes of supercritical carbon dioxide-processed cadaveric fascia lata pubovaginal sling for female stress urinary incontinence: a prospective single-surgeon cohort

Judith T. W. Goh, H Kyaw, Hannah G. Krause, Yu Hwee Tan, Vivien Wong
preprint en

Abstract

Abstract Purpose Supercritical carbon dioxide (SCCO 2 ) processing may preserve the structural properties of cadaveric fascia while avoiding donor-site morbidity associated with autologous fascial harvest. Clinical outcomes of SCCO₂-processed fascia lata have not previously been reported in continence surgery. Our study evaluated efficacy and safety outcomes following SCCO₂-processed cadaveric fascia lata pubovaginal sling (PVS) surgery for female stress urinary incontinence (SUI). Methods This prospective, single-centre, single-surgeon observational cohort included 24 consecutive women undergoing SCCO₂-processed fascia lata PVS surgery. Patient-reported outcomes were assessed using the International Consultation on Incontinence Questionnaire–Urinary Incontinence Short Form (ICIQ-UI SF) and Patient Global Impression of Improvement (PGI-I) at 6 weeks, 6 months and 12 months. Primary outcome was change in ICIQ-UI SF and PGI-I from baseline to 12 months. Perioperative and graft-related complications were recorded prospectively. Results Baseline median ICIQ-UI SF was 15.5 (IQR 14–16). Twelve-month outcome data were available for 18 participants with a median ICIQ-UI SF of 4 (IQR 0–6), and a median within-participant improvement of 11 points (IQR 9–15; p<0.001). Thirteen (72.2%) reported being “very much better” on PGI-I; subjective SUI cure / improvement were reported by 17/18 (94.4%). Graft exposure occurred in 3/24 (12.5%). Conclusion SCCO₂-processed cadaveric fascia lata PVS was associated with substantial improvement in patient-reported continence outcomes at 12 months. These preliminary findings support further prospective evaluation with larger comparative cohorts and longer follow-up.

Research Square
Griffith University (AU), Bond University (AU), Greenslopes Private Hospital (AU)
Good health and well-being
Pelvic floor disorders treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon